Spineart secured a 30MM (~US $33MM) investment. Proceeds will support sales, geographical expansion in markets such as the U.S. and Europe and product development.
Zimmer Biomet launched the Vanguard® Individualized Design total knee construct, offering two individual polyethylene bearings with different articulations to support a patient-specific fit.
OSTEOGROW, an EU-funded collaborative research project, is investigating a new bone regeneration therapy based on autologous blood + BMP-6 for use in applications requiring partial bone replacement, without the need for secondary interventions.
RTI Surgical received regulatory clearance for nanOss® Bioactive bone void filler in Australia, as well as CE Mark for nanOss Bioactive Loaded and nanOss Bioactive 3D in Europe.
Bioventus launched the EXOGEN® Ultrasound Bone Healing System in Saudi Arabia for distribution by Zimmo Trading Company, which also markets DUROLANE® single-injection hyaluronic acid osteoarthritis treatment.